The WACC of PCC Rokita SA (PCR.WA) is 10.0%.
Range | Selected | |
Cost of equity | 10.00% - 14.40% | 12.20% |
Tax rate | 13.10% - 15.60% | 14.35% |
Cost of debt | 4.90% - 6.70% | 5.80% |
WACC | 8.3% - 11.8% | 10.0% |
Category | Low | High |
Long-term bond rate | 5.5% | 6.0% |
Equity market risk premium | 6.3% | 7.3% |
Adjusted beta | 0.72 | 1.07 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 10.00% | 14.40% |
Tax rate | 13.10% | 15.60% |
Debt/Equity ratio | 0.43 | 0.43 |
Cost of debt | 4.90% | 6.70% |
After-tax WACC | 8.3% | 11.8% |
Selected WACC | 10.0% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for PCR.WA:
cost_of_equity (12.20%) = risk_free_rate (5.75%) + equity_risk_premium (6.80%) * adjusted_beta (0.72) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.